| scholarly article | Q13442814 |
| P2093 | author name string | Wei Wang | |
| Yuan Wang | |||
| Qiong Wang | |||
| Yan Zheng | |||
| Yongping Shao | |||
| Jinjing Jia | |||
| Zhengxiao Li | |||
| Huling Yan | |||
| P2860 | cites work | Two human genes isolated by a novel method encode DNA-binding proteins containing a common region of homology | Q24294626 |
| Identification of the cathelicidin peptide LL-37 as agonist for the type I insulin-like growth factor receptor | Q24306866 | ||
| Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
| LL-37, the only human member of the cathelicidin family of antimicrobial peptides | Q28241675 | ||
| Nuclear translocation of the Y-box binding protein by ultraviolet irradiation | Q28257567 | ||
| Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cells | Q28535383 | ||
| The pro-inflammatory peptide LL-37 promotes ovarian tumor progression through recruitment of multipotent mesenchymal stromal cells. | Q30486489 | ||
| Leucine leucine-37 uses formyl peptide receptor-like 1 to activate signal transduction pathways, stimulate oncogenic gene expression, and enhance the invasiveness of ovarian cancer cells. | Q30490685 | ||
| Treatment with LL-37 peptide enhances antitumor effects induced by CpG oligodeoxynucleotides against ovarian cancer | Q33792003 | ||
| Emerging roles of the host defense peptide LL-37 in human cancer and its potential therapeutic applications. | Q34091593 | ||
| NF-κB, an active player in human cancers | Q34138728 | ||
| LL‐37 as a therapeutic target for late stage prostate cancer | Q34511108 | ||
| Tumor-produced versican V1 enhances hCAP18/LL-37 expression in macrophages through activation of TLR2 and vitamin D3 signaling to promote ovarian cancer progression in vitro | Q34592889 | ||
| Palliative therapy of disseminated malignant melanoma: a systematic review of 41 randomised clinical trials. | Q35603108 | ||
| Epidermal growth factor receptor (EGFR) is transcriptionally induced by the Y-box binding protein-1 (YB-1) and can be inhibited with Iressa in basal-like breast cancer, providing a potential target for therapy | Q36458742 | ||
| YB-1, the E2F pathway, and regulation of tumor cell growth | Q36755479 | ||
| Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer | Q37205544 | ||
| Tumors sound the alarmin(s). | Q37243109 | ||
| Cathelicidin LL-37: a multitask antimicrobial peptide | Q37668182 | ||
| Y-box-binding protein 1 (YB-1) and its functions | Q37984603 | ||
| YB-1: oncoprotein, prognostic marker and therapeutic target? | Q38065264 | ||
| Y-box binding protein 1--a prognostic marker and target in tumour therapy | Q38181719 | ||
| Cantharidin impairs cell migration and invasion of A375.S2 human melanoma cells by suppressing MMP-2 and -9 through PI3K/NF-κB signaling pathways | Q38911160 | ||
| The antimicrobial peptide human cationic antimicrobial protein-18/cathelicidin LL-37 as a putative growth factor for malignant melanoma. | Q39639712 | ||
| P300/CBP-associated factor regulates Y-box binding protein-1 expression and promotes cancer cell growth, cancer invasion and drug resistance. | Q39701578 | ||
| LL-37 stimulates the functions of adipose-derived stromal/stem cells via early growth response 1 and the MAPK pathway | Q39838058 | ||
| Host defence peptide LL-37 induces IL-6 expression in human bronchial epithelial cells by activation of the NF-kappaB signaling pathway. | Q39900346 | ||
| The human endonuclease III enzyme is a relevant target to potentiate cisplatin cytotoxicity in Y-box-binding protein-1 overexpressing tumor cells | Q40007855 | ||
| Ovarian cancers overexpress the antimicrobial protein hCAP-18 and its derivative LL-37 increases ovarian cancer cell proliferation and invasion | Q40062395 | ||
| The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells | Q40086400 | ||
| Overexpression of coxsackie and adenovirus receptor inhibit growth of human bladder cancer cell in vitro and in vivo | Q40132212 | ||
| The increased expression of Y box-binding protein 1 in melanoma stimulates proliferation and tumor invasion, antagonizes apoptosis and enhances chemoresistance. | Q40176953 | ||
| Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells. | Q40479004 | ||
| The antimicrobial peptide LL-37 activates innate immunity at the airway epithelial surface by transactivation of the epidermal growth factor receptor. | Q40609292 | ||
| The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma | Q44919330 | ||
| Antimicrobial peptide LL37 promotes vascular endothelial growth factor-A expression in human periodontal ligament cells | Q45405723 | ||
| Recent trends of cutaneous leishmaniasis in Alert Hospital, Addis Ababa | Q46910496 | ||
| Y-box binding protein-1 is a novel molecular target for tumor vessels | Q48234561 | ||
| Twist promotes tumor cell growth through YB-1 expression. | Q53507465 | ||
| Molecular events in melanoma development and progression | Q77309976 | ||
| Prognostic implications of the nuclear localization of Y-box-binding protein-1 and CXCR4 expression in ovarian cancer: their correlation with activated Akt, LRP/MVP and P-glycoprotein expression | Q80216629 | ||
| The over expression of cathelicidin peptide LL37 in head and neck squamous cell carcinoma: the peptide marker for the prognosis of cancer | Q84312777 | ||
| P433 | issue | 1 | |
| P921 | main subject | cell migration | Q189092 |
| antimicrobial peptide | Q1201508 | ||
| P304 | page(s) | 240-248 | |
| P577 | publication date | 2016-12-02 | |
| P1433 | published in | Molecular Medicine Reports | Q26842180 |
| P1476 | title | Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells | |
| P478 | volume | 15 |
| Q89326760 | Detection of a MicroRNA molecular signature of ultraviolet radiation in the superficial regions of melanocytic nevi on sun-exposed skin |
| Q91782691 | Granzyme A Stimulates pDCs to Promote Adaptive Immunity via Induction of Type I IFN |
| Q64277502 | Myeloid cell-derived LL-37 promotes lung cancer growth by activating Wnt/β-catenin signaling |
| Q54977356 | miR372 Promotes Progression of Liver Cancer Cells by Upregulating erbB-2 through Enhancement of YB-1. |
Search more.